choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Evista

Evista Newsletter
  • Immediate Evista Review 2025: Scam or Legit Trading Platform? – Facts! 30 Jan 2025 06:28 GMT

    … Start Trading on Immediate Evista? The Immediate Evista crypto trading bot follows … can use the demo or trial mode with simulated funds to … payment methods available on Immediate Evista? Immediate Evista supports several secure payment …

  • Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval 14 Oct 2024 21:56 GMT

    … + Lomb Corporation announced the FDA has granted approval to the … : Yeah, thanks, David. Well, eVista Envy offers a continuous range … little bit about the clinical trials and patient outcomes that … summer, we acquired Trukera Medical and its ScoutPro point-of …

  • Breast Cancer Screening and Treatment Update 18 Sep 2024 16:27 GMT

    drugs, primarily targeted therapies, have recently been FDA approved for treatment … , and medications. The … Relevant to Evista trial, raloxifene … Pharmaceutical Corp; March 2022. 29. Nerlynx (neratinib) product information. Los Angeles, CA: Puma Biotechnology, …

  • Athira Pharma Welcomes Dr. Javier San Martin as Chief Medical Officer 15 Apr 2024 14:03 GMT

    … “Javier’s decades of drug development experience will be … the first-in-human trial of ATH-1105 … better treatment options.” San Martin joins Athira from Arrowhead Pharmaceuticals, … trials to support the successful launch and medical affairs activities for Evista

  • Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer 15 Apr 2024 11:00 GMT

    … as a pioneer in drug development for patients with … the first-in-human trial of ATH-1105 in … treatment options.” Dr. San Martin joins Athira from Arrowhead Pharmaceuticals, … trials to support the successful launch and medical affairs activities for Evista

  • Global Postmenopausal Osteoporosis Treatment Market is Expected to Reach US$ 15,171.90 million by 2034 | Future Market Insights, Inc. Projection 24 Nov 2023 12:30 GMT

    … activities for generation of drugs and growing awareness about … Evista), a selective estrogen receptor modulator used in osteoporosis treatment. Teva Pharmaceutical … of various osteoporosis medications, contributing to treatment accessibility. Market Key …

  • Causes and treatment for leg cramps 14 Jul 2023 02:47 GMT

    … (Venofer) conjugated estrogens raloxifene (Evista) naproxen (Aleve) teriparatide (Forteo … , the Food and Drug Administration (FDA) urge people not … probably get better without treatment. Walking on tiptoes … idea to seek medical advice. The doctor may carry out …

  • What medications are available to treat breast cancer? 31 Jan 2023 19:23 GMT

    treatment option. In August 2022, the Food and Drug Administration (FDA) … Pharmorubicin) HER2-positive A doctor will prescribe chemotherapy alongside … a clinical trial, which may cover medical costs asking … if the pharmaceutical company of the drug offers a …

  • 10 Most Fined Pharmaceutical Companies in the World 10 Jan 2023 14:59 GMT

    pharmaceutical corporations suppress natural alternative remedies so they can sell their drugs … a different method of treatment. This is why even … Journal of the American Medical Association which carried … settlement related to a biotech company in the history …

  • Selective estrogen receptor modulators (SERMs) Market Dynamics: Significant Expansion Anticipated, 2034 | DelveInsight 26 Dec 2024 16:50 GMT

    … DUAVEE, EVISTA, and … Sermonix Pharmaceuticals, and others … FDA-approved Selective estrogen receptor modulators (SERMs) @ Selective estrogen receptor modulators (SERMs) Drugstrials, visit @ Selective estrogen receptor modulators (SERMs) Treatment Drugs

Satisfied with the content?

Continue to create your account.